Ideal Taxes Association

Raymond Richman       -       Jesse Richman       -       Howard Richman

 Richmans' Trade and Taxes Blog

God's Providence at work: The Israeli COVID-19 vaccine
Howard Richman, 3/11/2020

Israeli scientists have developed an oral COVID-19 vaccine. The latest report is from, a website that reports Israeli innovation news:

While working on the avian [coronavirus] vaccine, the scientists [at the MIGAL Galilee Research Institute] said they identified a possible COVID-19 vaccine candidate as a by-product of the [avian] vaccine and have made the “required genetic adjustments to adapt the vaccine to COVID-19, the human strain of coronavirus.”...

“It’s a little bit like fate that we were working on this coronavirus vaccine at the same time that the world was suddenly hit by this epidemic of coronavirus for humans,” [Dr. Shahar of MIGAL] says.

The MIGAL vaccine was created by synthesizing two proteins. Unlike vaccines that are created by injecting a dead or weakened disease-causing viruses, there is very little danger of the MIGAL vaccine giving patients a disease.

The main danger with synthetic vaccines is that they will only work in the test tube, not in-vivo. But the researchers at MIGAL have already proven in clinical trials that the avian version of their vaccine works in live chickens.

Most vaccines create antibodies in the bloodstream – not this one! This one creates antibodies in the mucosal immune system which consists of thin permeable barriers to infection in the lungs, gut, eyes, nose, throat, uterus and vagina. The website quotes Dr. Chen Katz, MIGAL’s biotechnology group leader saying:

[T]he protection [provided by the vaccine] is in the mucosal tissues which affect the respiratory and intestinal systems. And we know that this is how COVID-19 works, by affecting these systems.

So far, the American media and the U.S. health bureaucracy have totally ignored the MIGAL vaccine. On March 10, there were no U.S. media hits in the first 10 pages of a Google search for the three words: (1) MIGAL, (2) coronavirus and (3) vaccine. The third hit down on Google’s list from correctly claimed that, as of February, the Israelis had not yet adapted their vaccine to COVID-19. According to, that is no longer true.

The U.S. government’s health bureaucracy has been fumbling the ball on the COVID-19 virus. The first infection detection kits that they sent out didn’t work. Their original guidelines for who should be tested left people out who were contagious. As a result, the virus escaped from quarantine. The virus could still possibly be contained without the help of a vaccine, but probably not.

Meanwhile, NIAID coordinator Anthony Fauci has been telling everyone who will listen, “It will take at least a year to a year and a half to have a vaccine we can use.” Has he been announcing that the U.S. health bureaucracy plans to slow-walk a successful vaccine until after the November election?

So far, they have only given the go-ahead for safety-testing a single COVID-19 vaccine, the Messenger RNA vaccine developed by U.S.-based Moderna Therapeutics which, unlike the MIGAL vaccine, has not yet proven itself in-vivo. The Times of Israel had an update on MIGAL’s vaccine on March 11:

Chen Katz [of  MIGAL] told The Times of Israel that the new oral vaccine for adults and children could “turn this disease into a very mild cold.” He said that for many people who are inoculated and then infected by COVID-19, “potentially it will not affect them at all.”…

The vaccine will consist of a specially produced protein, and Katz said he expects to be clutching a bottle of it within “a few weeks.” But then comes clinical testing, which will take place in conjunction with a partner, and the paperwork, both of which will take time.

Katz, Biotechnology Group Leader at the institute, said: “By the time the protein is ready, we hope to have found the right partner who can take us through the clinical stage. The clinical testing experiments themselves are not so long, and we can complete them in 30 days, plus another 30 days for human trials. Most of the time is bureaucracy — regulation and paperwork.”

Time could also be lost because of “waiting points” between the different stages of the process, until regulators give the nod for things to move forward.

The MIGAL vaccine should be quickly put through trials. The Trump administration needs to intervene to eliminate all paperwork delays. The U.S. government’s health bureaucracy should not be permitted to slow-walk God’s providence until after the November election. MIGAL’s COVID-19 vaccine should be made available to the public as soon as possible!

Your Name:

Post a Comment:

Comment by Howard Richman, 3/13/2020:

The Israeli government is moving forward to test the vaccine on humans. It could be proven in as little as three months. Here's the link:

  • Richmans' Blog    RSS
  • Our New Book - Balanced Trade
  • Buy Trading Away Our Future
  • Read Trading Away Our Future
  • Richmans' Commentaries
  • ITA Working Papers
  • ITA on Facebook
  • Contact Us

    Jan 2022
    Dec 2021
    Nov 2021
    Oct 2021
    Sep 2021
    May 2021
    Apr 2021
    Feb 2021
    Jan 2021
    Dec 2020
    Nov 2020
    Oct 2020
    Jul 2020
    Jun 2020
    May 2020
    Apr 2020
    Mar 2020

    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    March 2012
    February 2012
    January 2012
    December 2011
    November 2011
    October 2011
    September 2011
    August 2011
    July 2011
    June 2011
    May 2011
    April 2011
    March 2011
    February 2011
    January 2011
    December 2010
    November 2010
    October 2010
    September 2010
    August 2010
    July 2010
    June 2010
    May 2010
    April 2010
    March 2010
    February 2010
    January 2010

    Book Reviews
    Capital Gains Taxation
    Corporate Income Tax
    Consumption Taxes
    Economy - Long Term
    Economy - Short Term
    Environmental Regulation
    Last 100 Years
    Last 100 Years
    Real Estate Taxation

    Outside Links:

  • American Economic Alert
  • American Jobs Alliance
  • Angry Bear Blog
  • Economy in Crisis
  • Econbrowser
  • Emmanuel Goldstein's Blog
  • Levy Economics Institute
  • McKeever Institute
  • Michael Pettis Blog
  • Naked Capitalism
  • Natural Born Conservative
  • Science & Public Policy Inst.
  • Votersway Blog
  • Watt's Up With That


  • [An] extensive argument for balanced trade, and a program to achieve balanced trade is presented in Trading Away Our Future, by Raymond Richman, Howard Richman and Jesse Richman. “A minimum standard for ensuring that trade does benefit all is that trade should be relatively in balance.” [Balanced Trade entry]

    Journal of Economic Literature:

  • [Trading Away Our Future] Examines the costs and benefits of U.S. trade and tax policies. Discusses why trade deficits matter; root of the trade deficit; the “ostrich” and “eagles” attitudes; how to balance trade; taxation of capital gains; the real estate tax; the corporate income tax; solving the low savings problem; how to protect one’s assets; and a program for a strong America....

    Atlantic Economic Journal:

  • In Trading Away Our Future   Richman ... advocates the immediate adoption of a set of public policy proposal designed to reduce the trade deficit and increase domestic savings.... the set of public policy proposals is a wake-up call... [February 17, 2009 review by T.H. Cate]